NasdaqGM - Delayed Quote • USD
Veracyte, Inc. (VCYT)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:22 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 7 |
Avg. Estimate | -0.17 | -0.07 | -0.3 | 0 |
Low Estimate | -0.22 | -0.1 | -0.36 | -0.28 |
High Estimate | -0.14 | -0.04 | -0.2 | 0.33 |
Year Ago EPS | -0.11 | -0.12 | -1.02 | -0.3 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 9 | 9 |
Avg. Estimate | 93.37M | 98.75M | 397.84M | 443.37M |
Low Estimate | 91.2M | 97.2M | 394M | 437.7M |
High Estimate | 95.66M | 101.45M | 400.67M | 451.22M |
Year Ago Sales | 75.81M | 90.32M | 361.05M | 397.84M |
Sales Growth (year/est) | 23.20% | 9.30% | 10.20% | 11.40% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.13 | -0.15 | -0.15 | -0.09 |
EPS Actual | -0.11 | -0.12 | -0.41 | -0.39 |
Difference | 0.02 | 0.03 | -0.26 | -0.3 |
Surprise % | 15.40% | 20.00% | -173.30% | -333.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.17 | -0.07 | -0.3 | 0 |
7 Days Ago | -0.17 | -0.07 | -0.3 | 0 |
30 Days Ago | -0.17 | -0.07 | -0.3 | 0 |
60 Days Ago | -0.15 | -0.07 | -0.28 | -0.01 |
90 Days Ago | -0.09 | -0.07 | -0.26 | -0.03 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 1 | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | VCYT | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -54.50% | -- | -- | 5.40% |
Next Qtr. | 41.70% | -- | -- | 10.90% |
Current Year | 70.60% | -- | -- | 4.50% |
Next Year | 100.00% | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 10.94% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Goldman Sachs: Buy to Buy | 4/15/2024 |
Maintains | Morgan Stanley: Underweight to Underweight | 2/26/2024 |
Maintains | Needham: Buy to Buy | 2/23/2024 |
Maintains | Morgan Stanley: Underweight to Underweight | 11/10/2023 |
Maintains | Needham: Buy to Buy | 11/8/2023 |
Maintains | Goldman Sachs: Buy to Buy | 10/23/2023 |
Related Tickers
CDNA CareDx, Inc
7.56
0.00%
MYGN Myriad Genetics, Inc.
18.18
+1.11%
BDSX Biodesix, Inc.
1.2350
-1.98%
TWST Twist Bioscience Corporation
31.54
+1.48%
PSNL Personalis, Inc.
1.2650
+1.20%
NTRA Natera, Inc.
91.66
+0.42%
OLK Olink Holding AB (publ)
22.84
-1.00%
WAT Waters Corporation
311.30
+0.96%
EXAS Exact Sciences Corporation
58.85
+0.10%
IQV IQVIA Holdings Inc.
234.88
+0.38%